Both the Northwestern boys and girls basketball teams clinched district playoff berths with wins on Thursday. Both Tiger ...

This article originally appeared on Burlington Free Press: Vermont H.S. scores for April 18: See how your favorite team fared The 2023 Vermont high school spring season has begun. See below for scores ...

Allen and Harbour initially put their marital abode on the market for $7.99 million, months after it was revealed they had ...

Eli Lilly has shown patients maintained most of their weight loss after switching from injectable GLP-1s to its oral drug candidate, teeing the drugmaker up to target people taking Novo Nordisk’s ...

Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also looks ripe to announce a stock split. Eli Lilly's shares look attractive ...

The recent rotation into healthcare stocks and out of hot technology plays can be epitomized by the strong outperformance of Eli Lilly shares relative to Nvidia’s stock. Since the tech sector peaked ...

A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet. The ...

Eli Lilly’s weight loss drugs have delivered blockbuster sales in recent quarters. The company is a leader in this market today and has a pipeline of promising candidates to potentially reinforce its ...

Lenovo is refreshing its ThinkPad X1 laptops with some exciting new hardware upgrades, not the least of which is the debut of ...

Eli Lilly is positioned for a secular growth trajectory, leveraging its duopoly in diabetes and obesity therapies while investing heavily in pipeline diversification. LLY faces intensifying ...

Eli Lilly LLY-0.47%decrease; red down pointing triangle said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, ...

FDA chief's office said it wants to cut the filing review from 60 days to one week The office said it may cut those reviews to two or three weeks based on complexity The agency could decide on Lilly's ...